Paediatric Autism Communication Therapy (PACT) in Children With Autism Spectrum Disorder

Not Applicable

Recruiting

• Conditions: Autism Spectrum Disorder

• Registration Number: NCT05673096
• Lead Sponsor: University of Southern Denmark

Brief Summary

Paediatric Autism Communication Therapy (PACT) is a naturalistic developmental behavioural interventions to reduce autism symptoms. The aim of this trial is to assess the beneficial and harmful effects of PACT in 2-6 year-old children with a recent diagnosis of autism spectrum disorder.

Detailed Description

Autism spectrum disorder (ASD) is a neurodevelopmental disorder affecting approximately 2% of children and young people worldwide. ASD is considered a lifelong disorder and interventions significantly reducing the core autistic symptoms have been sparse. Paediatric Autism Communication Therapy (PACT) is among the first naturalistic developmental behavioural interventions to show promising results for reduction in autism symptoms.

The aim of this trial is to assess the beneficial and harmful effects of PACT in 2-6 year-old children with a recent diagnosis of ASD.

This trial is an investigator-initiated, independently funded, pragmatic, national, parallel group, superiority, randomised clinical trial comparing PACT combined with management as usual to management as usual alone.

Study Timeline

• Study First Submitted: 2022-12-22
• Study First Submitted QC: 2022-12-22
• Study First Posted: 2023-01-06
• Study Start: 2023-03-13
• Status Verified: 2024-12
• Last Update Submitted: 2024-12-05
• Last Update Posted: 2024-12-11
• Primary Completion: 2026-03-01
• Study Completion: 2026-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 280

Inclusion Criteria

• Children aged 2 through 6 years (both inclusive)
• A diagnosis of ASD meeting the criteria for International Classification of Diseases; Tenth Edition (ICD-10): Diagnose codes: DF84.0, DF84.1, DF84.5, DF84.8
• An Autism Diagnostic Observation Schedule, 2nd Edition Calibrated Severity Score (ADOS-2 CSS) ≥ 4
• The ASD diagnosis must be verified by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), Autism Spectrum Disorder Checklist
• The ASD diagnosis must be the primary developmental disorder (comorbid conditions allowed) and conferred at a clinical conference
• Parents must have sufficient Danish (or English) language skills to communicate with the therapist
• Signed informed consent by parents or holders of legal guardianship

Exclusion Criteria

• Children having a sibling already included in the trial
• Hearing and visual impairment in child or parent
• Parent not available for regular sessions with the therapist, evaluated at the consent meeting

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Autism Symptoms	End of intervention (14 months)	Autism symptoms are measured by Diagnostic Observation schedule, 2nd Edition, Calibrated Severity Score (ADOS-2 CSS). Range 0-10, with 10 indicating the highest symptom severity.

Secondary Outcome Measures

Name	Time	Method
Quality of Life (child)	End of intervention (14 months)	Parents' assessment of their child's quality of life with Pediatric Quality of Life Inventory (PEDSQL), a questionnaire including 23 items covering four dimensions of health related quality of life. Each item is rated between 0 and 100. A higher score indicates a higher level of health-related quality of life. The mean item score is used as outcome.
Quality of life (parents)	End of intervention (14 months)	Parent quality of life is measured by the questionnaire World Health Organization Quality of Life assessment- BREF (WHOQOL-BREF), including 28 items of quality of life for parents in 4 dimensions: Physiological, emotional, social and context. The item scores range from 1 to 5 with higher scores denoting higher quality of life. As the number of items differs for each subscale, the mean item score is used as outcome.
Child adaptive functioning	End of intervention (14 months)	Child adaptive functioning, or personal and social skills needed for everyday living will be measured by the Vineland Adaptive Behavior Scales, 3rd Edition (VABS-3), an online questionnaire filled in by parents. Each of four domains, Communication, Daily Living Skills, Socialization and Motor Skills are divided into 3 sub-domains. Each item is scored on a Likert-type format with scores 0 (never), 1(sometimes), and 2 (usually or often). Individual items scores are summed to a raw composite score and converted into a standard scale scores. Higher scores indicate higher functioning.
Social interaction of the child	At 6 month and end of intervention (14 months)	Brief Observation of Social Communication Change (BOSCC) is rated on a 12-minute videotaped parent-child play-session. Each of the 15 behavioural items is coded using an empirically based decision tree that captures information regarding the behaviour including frequency and quality. Each item is rated on a 6- point scale from 0 (abnormality is not present) to 5 (abnormality is present and significantly impairs functioning). For measuring change only item 1-12 (range 0-60) are used.

Trial Locations

Locations (6)

Child and Adolescent Mental Health Center, Aabenraa, Region of Southern Denmark; 🇩🇰 Aabenraa, Denmark

Child and Adolescent Mental Health Center, Aalborg, North Denmark Region; 🇩🇰 Aalborg, Denmark

Child and Adolescent Psychiatric Dept., Skejby, Aarhus University Hospital; 🇩🇰 Aarhus, Denmark

Child and Adolescent Mental Health Center, Capital Region of Denmark; 🇩🇰 Hellerup, Denmark

Child and Adolescent Mental Health Center, Odense, Region of Southern Denmark; 🇩🇰 Odense, Denmark

Department of Child and Adolescent Psychiatry, Copenhagen University Hospital; 🇩🇰 Roskilde, Denmark